Osteosarcoma in dogs — should I amputate?

The short answer

Osteosarcoma — the classic large-breed bone cancer — is one of the few cancers where surgery is mainly about pain relief, not cure. Amputation usually transforms a dog in distress into one who can move comfortably for the next 6–12 months. The question to answer honestly before consenting to the surgery: can my specific dog adapt to three legs, and what is the trajectory of the cancer afterwards?

The pain — why this is different

Bone cancer pain is mechanical and continuous. The tumour erodes the cortex, producing micro-fractures and inflammation. Standard NSAID analgesia is partly effective; opioids and gabapentin layer on top; bisphosphonates (pamidronate, zoledronate) reduce osteoclastic destruction and pain. Even with multimodal analgesia at maximum, owner reports of pain control are often less than 7/10. The dog is uncomfortable continuously, with worse moments on movement.

This is the framing that shifts the amputation conversation: amputation is not a treatment of the cancer, it is the most reliable analgesic.

What amputation does

Removes the painful limb in its entirety. Most dogs, post-surgery, are noticeably more comfortable within 48 hours. The chronic pain that dominated their behaviour is gone.

What it does not do: prevent metastasis. By the time osteosarcoma is diagnosed, microscopic tumour cells have almost always disseminated, most commonly to the lungs. Chemotherapy after amputation (carboplatin or doxorubicin) targets these micrometastases and extends survival.

Who does well on three legs

Most large-breed dogs adapt well. Predictors of good adaptation:

• Otherwise good mobility before surgery (walks normally on remaining limbs).
• Body condition score 4–6 of 9; obesity is the biggest single predictor of struggle.
• No significant arthritis or neurological disease in another limb.
• Strong abdominal core; dogs with intact musculature compensate faster.

Predictors of struggle:

• Severe arthritis in another limb.
• Obesity (BCS 8 or 9).
• Spinal disease (IVDD, degenerative myelopathy).
• Pre-existing weakness on the contralateral limb.

Age alone is not a strong predictor. A 12-year-old otherwise-mobile Lab adapts faster than a 6-year-old obese German Shepherd.

Survival numbers

• Amputation alone: 4–6 months median.
• Amputation + carboplatin or doxorubicin: 11–12 months median.
• No surgery; analgesic palliation only: 2–4 months, with welfare deteriorating across that window.
• Limb-spare surgery (selected cases): similar survival to amputation when feasible.

Limb-sparing alternatives

For dogs in whom amputation is not feasible (severe contralateral disease) or whom the owner specifically wishes to keep on four legs, two alternatives:

• Limb-sparing surgery. The affected bone is excised and replaced with allograft, endoprosthesis, or bone-transport reconstruction. Available at referral centres; complication rate higher than amputation. Best candidate: distal radius lesion in a thoracic-limb-only OSA.
• Stereotactic body radiation therapy (SBRT). High-dose, focused radiation to the tumour. Good pain control in 3–4 weeks; modest survival extension. Available at specialised oncology centres.

The decision framework

Five questions, in order:

1. How well does my dog move now, on four legs? If poorly, three legs will be harder.
2. What is the body condition score? Obesity is the biggest single barrier; pre-surgical weight management is sometimes appropriate.
3. What does my dog do for fun? A dog whose joys involve running off-leash long distances will struggle more than a dog who enjoys quiet walks.
4. Can I sustain post-surgical care for 14 days? The first two weeks are intensive; planning is essential.
5. Have I spoken to an owner who has been through this? The lived experience often calibrates expectations more usefully than statistics.

Editorial reference, not veterinary advice. — Dr. NRS, last reviewed 28 April 2026.